BAG1 is a co-chaperone that functions as a nucleotide-exchange factor for HSP70 and HSC70 heat shock proteins, promoting the release of ADP and triggering substrate protein release. This cochaperone activity occurs through BAG1 binding to both the nucleotide-binding domain and substrate-binding domain of HSC70/HSPA8. Beyond protein folding, BAG1 exhibits anti-apoptotic functions by inhibiting the pro-apoptotic protein PPP1R15A and markedly enhancing the cell-death-inhibiting activity of BCL2. BAG1 exists as four isoforms (BAG1L, BAG1M, BAG1S, and BAG1 p29) with distinct subcellular localizations and functional patterns 1. BAG1 plays context-dependent roles in cancer: in breast cancer, BAG1 and BAG1L overexpression promote cell survival under serum deprivation and enhance tumor growth in xenograft models 2, whereas in liposarcoma, low BAG1 expression associates with worse prognosis and increased regulatory T cells, suggesting BAG1 acts as a protective factor in this context 3. Recent evidence indicates BAG1 participates in neuronal proteostasis through interactions with EVA1C isoforms and the HSP70 chaperone network, facilitating selective autophagy and proteasomal degradation of misfolded proteins including tau 4. BAG1 additionally regulates quality control of misfolded potassium channels at the endoplasmic reticulum through recruitment of the E3 ligase TRC8 5. At the tissue level, BAG1 emerges as a melanoma biomarker with differential gene and protein expression 6.